Researcher:
Kara, İlayda Arjen

Loading...
Profile Picture
ORCID

Job Title

Undergraduate Student

First Name

İlayda Arjen

Last Name

Kara

Name

Name Variants

Kara, İlayda Arjen

Email Address

Birth Date

Search Results

Now showing 1 - 1 of 1
  • Thumbnail Image
    PublicationOpen Access
    Systematic review and meta-analysis of postexposure prophylaxis for Crimean-Congo hemorrhagic fever virus among healthcare workers
    (Centers for Disease Control and Prevention (CDP), 2018) Keske, Şiran; Pshenichnaya, Natalia; Abuova, Gulzhan; Blumberg, Lucille; Gönen, Mehmet; N/A; Ergönül, Önder; Çeldir, Melis Gökçe; Kara, İlayda Arjen; Faculty Member; School of Medicine; Graduate School of Health Sciences; 110398; N/A; N/A
    We performed a systematic review and meta-analysis on the effectiveness of ribavirin use for the prevention of infection and death of healthcare workers exposed to patients with Crimean-Congo hemorrhagic fever virus (CCHFV) infection. Splashes with blood or bodily fluids (odds ratio [OR] 4.2), being a nurse or physician (OR 2.1), and treating patients who died from CCHFV infection (OR 3.8) were associated with healthcare workers acquiring CCHFV infection; 7% of the workers who received postexposure prophylaxis (PEP) with ribavirin and 89% of those who did not became infected. PEP with ribavirin reduced the odds of infection (OR 0.01, 95% CI 0-0.03), and ribavirin use <= 48 hours after symptom onset reduced the odds of death (OR 0.03, 95% CI 0-0.58). The odds of death increased 2.4-fold every day without ribavirin treatment. Ribavirin should be recommended as PEP and early treatment for workers at medium-to-high risk for CCHFV infection.